JosephPhilipVacantiMD
Pediatric (General) Surgery • Boston, MAJohn Homans Professor of Surgery, Massachusetts General Hospital
Are you Dr. Vacanti?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 89 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
55 Fruit St
Wrn 1157
Boston, MA 02114Phone+1 617-724-1725Fax+1 617-726-7593- Is this information wrong?
Summary
- Dr. Joseph Vacanti, MD is a Pediatric Surgeon in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is a John Homans Professor of Surgery at Massachusetts General Hospital.
Education & Training
Massachusetts General HospitalResidency, Surgery, 1979 - 1980- Massachusetts General HospitalResidency, Surgery, 1974 - 1977
University of Nebraska College of MedicineClass of 1974
Certifications & Licensure
MA State Medical License 1974 - 2025
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 2001
- Fellow (FAAP) American Academy of Pediatrics
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- Thirtieth Anniversary of Tissue Engineering: A Congratulations and a Few Thoughts.Vacanti, J.> ;Tissue Engineering. Part A. 2024 Feb 1
- 10 citationsTissue engineering: from the bedside to the bench and back to the bedsideTatevik Sahakyants, Joseph P. Vacanti> ;Pediatric Surgery International. 2020 Jul 30
- 8 citationsDecellularized extracellular matrix microparticles seeded with bone marrow mesenchymal stromal cells for the treatment of full-thickness cutaneous wounds:Amanda M Westman, Rachel L. Goldstein, Gino Bradica, Scott M. Goldman, Mark A. Randolph, Joseph P. Gaut, Joseph P. Vacanti, David M. Hoganson> ;Journal of Biomaterials Applications. 2019 Jan 16
- Join now to see all
Press Mentions
- InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord InjuryMarch 9th, 2023
- InVivo Therapeutics Announces Publication of 12- and 24-Month Data for INSPIRE 1.0 Study in Peer-Reviewed NeurosurgeryJune 8th, 2022
InVivo Therapeutics : Announces Participation at Upcoming H.C. Wainwright Annual Global Investment ConferenceSeptember 9th, 2021- Join now to see all
Grant Support
- Bioengineering Of Transplantable Humanized Lungs From IPS CellsNational Heart, Lung, And Blood Institute2011
- Tissue Engineering Of Blood Vessel SubstitutesNational Heart, Lung, And Blood Institute1999–2002
- Tissue Engineering Of Blood Vessel SubstitutesNational Heart, Lung, And Blood Institute1998
Professional Memberships
- Fellow
- Member
